To choose whether a parametric or a non-parametric test should be used to compare data on viability that emerge from an assay such as MTT, one should establish if the data are normally distributed. My question concerns to which group of samples a normal distribution test should be applied.

To be more clear I try to introduce an example.

Let's say I have to make a time and dose-response curve for two substances, A and B. I'd like to test both substances at 3 different concentrations ([1], [2], and [3]) and at three different time points (24h, 48h, and 72h). For each condition, I'd like to test 6 wells of a 96 mw plate. Obviously in each of my plates (let's say one per day) 6 wells will not receive any treatment and will thus represent my reference. This means that each plate would include 6x7 = 42 wells

As I said, after three days of data collection I would like to compare the treatments to understand if at any concentration or time point my molecules influence cell viability. Before choosing either a parametric (e.g., one way ANOVA) (e.g., Kruskal Wallis) I should establish whether or not the data are normally distributed.

I suppose that what I should test for normality are only those samples belonging to a single condition (let's say the 6 wells of untreated samples of the first plate), shouldn't I? Or maybe I should consider all the untreated samples of all plates together? Or even all samples together?

Thanks in advance

More Gianluca Occhi's questions See All
Similar questions and discussions